Subscribe now

Analysis and Health

mRNA trial shows promise for these therapies to revolutionise medicine

People with a rare condition experienced fewer or no complications after receiving an experimental mRNA therapy, with the technology having the potential to treat a range of disorders

By Michael Le Page

26 May 2023

An illustration of messenger ribonucleic acid (mRNA)

Kateryna Kon/Science Photo Library/Getty Images

Sixteen people have benefited from an experimental mRNA therapy that replaces a faulty enzyme behind a rare inherited condition, the biotech company Moderna announced on 19 May. This is great news for those with this condition, but its significance extends further: if this kind of mRNA therapy proves to be safe and effective, it could help treat a huge range of conditions and might even revolutionise medicine.

The people in the trial, aged 1 year and up, have a condition called propionic …

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 14th June 2023.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account